Page last updated: 2024-10-30

leflunomide and Infections, Prosthesis-Related

leflunomide has been researched along with Infections, Prosthesis-Related in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research Excerpts

ExcerptRelevanceReference
"Leflunomide is a DMARD that has a prolonged half-life due to enterohepatic recirculation."2.53Use of a Cholestyramine Washout in a Patient With Septic Shock on Leflunomide Therapy: A Case Report and Review of the Literature. ( Fraser, R; Kiser, TH; Kurche, J; Lara, A; Laub, M; Reynolds, PM, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laub, M1
Fraser, R1
Kurche, J1
Lara, A1
Kiser, TH1
Reynolds, PM1

Reviews

1 review available for leflunomide and Infections, Prosthesis-Related

ArticleYear
Use of a Cholestyramine Washout in a Patient With Septic Shock on Leflunomide Therapy: A Case Report and Review of the Literature.
    Journal of intensive care medicine, 2016, Volume: 31, Issue:6

    Topics: Aged; Antirheumatic Agents; Cholestyramine Resin; Female; Humans; Isoxazoles; Leflunomide; Prosthesi

2016